Scholar Rock Holding (SRRK) Non-Current Debt (2017 - 2026)

Scholar Rock Holding (SRRK) recorded quarterly Non-Current Debt of $196.6 million in Q1 2026, up 97.19% quarter-over-quarter from $99.7 million in Q4 2025, and up 295.28% on a YoY basis from $49.7 million in Q1 2025.

Scholar Rock Holding (SRRK) Non-Current Debt (2017 - 2026) Analysis & Trends

Scholar Rock Holding's Non-Current Debt history runs 10 years deep, the most recent figure standing at $196.6 million for Q1 2026.

  • In Q1 2026, Non-Current Debt rose 295.28% year-over-year to $196.6 million; the TTM figure through Mar 2026 stood at $196.6 million (up 295.28% YoY), while the FY2025 annual figure was $99.7 million, up 98.84% from the prior year.
  • Non-Current Debt was $196.6 million for Q1 2026 at Scholar Rock Holding, up from $99.7 million in the prior quarter.
  • In the past five years, Non-Current Debt ranged from a high of $196.6 million in Q1 2026 to a low of $38.8 million in Q2 2022.
  • Historically, Non-Current Debt has averaged $62.9 million across 5 years, with a median of $49.8 million in 2022.
  • The sharpest annual moves came in 2024 and 2026: Non-Current Debt slipped 10.51% in 2024, then jumped 295.28% in 2026.
  • A 5-year view of Non-Current Debt shows it stood at $49.7 million in 2022, then slipped by 2.13% to $48.7 million in 2023, then gained by 3.0% to $50.1 million in 2024, then jumped by 98.84% to $99.7 million in 2025, then soared by 97.19% to $196.6 million in 2026.
  • The last three Non-Current Debt figures came in at $196.6 million (Q1 2026), $99.7 million (Q4 2025), and $99.6 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 319.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - -
10 Scholar Rock Holding 6.03 Bn 5.55 Bn - 196.61 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 196.61 Mn
Mar 31, 2026 196.61 Mn
Dec 31, 2025 99.71 Mn
Dec 31, 2025 99.71 Mn
Sep 30, 2025 99.61 Mn
Sep 30, 2025 99.61 Mn
Jun 30, 2025 49.76 Mn
Jun 30, 2025 49.76 Mn
Mar 31, 2025 49.74 Mn
Mar 31, 2025 49.74 Mn
Dec 31, 2024 50.15 Mn
Dec 31, 2024 50.15 Mn
Sep 30, 2024 50.10 Mn
Sep 30, 2024 50.10 Mn
Jun 30, 2024 48.49 Mn
Jun 30, 2024 48.49 Mn
Mar 31, 2024 44.59 Mn
Mar 31, 2024 44.59 Mn
Dec 31, 2023 48.68 Mn
Dec 31, 2023 48.68 Mn